NIDA CTN Dissemination Initiative
ID: 75N95024R00039Type: Solicitation
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFNATIONAL INSTITUTES OF HEALTHNATIONAL INSTITUTES OF HEALTH NIDABethesda, MD, 20892, USA

NAICS

Administrative Management and General Management Consulting Services (541611)

PSC

SUPPORT- MANAGEMENT: OTHER (R799)

Set Aside

8(a) Set-Aside (FAR 19.8) (8A)

Original Source

https://sam.gov/opp/a9d23e3a4f9d4c2b90bbd6c0d742cb55/view
Timeline
    Description

    Sources Sought HEALTH AND HUMAN SERVICES, DEPARTMENT OF NATIONAL INSTITUTES OF HEALTH NIDA

    The NIDA CTN Dissemination Initiative is seeking qualified 8(a) small business sources to provide services for the dissemination of new scientific findings in substance use disorder treatment. The purpose of this initiative is to bridge the gap between research and practice and accelerate the adoption of evidence-based treatments. The contract will involve outreach to professional organizations and policymakers, mentor-facilitated training for early-career healthcare professionals, research dissemination projects, and the coordination of meetings and workshops. The contract will also support the development of electronic point of care products and innovative communication approaches. Interested small businesses must confirm their eligibility under the 8(a) program and provide relevant information on their capabilities and qualifications. The response deadline is January 17, 2023, at 2:00 PM Eastern Time.

    Files
    Title
    Posted
    RFP No. 75N95024R00039.pdf
    The National Institute on Drug Abuse (NIDA) is soliciting proposals for their CTN Dissemination Initiative, which aims to move drug abuse research into practice. The contract will be a cost-reimbursement contract for one base year with options for four additional years. The government requires at least 50% of the contract performance costs for personnel to be expended by employees of the small business firm.
    RFP No. 75N95024R00039 - Amendment 1.pdf
    Lifecycle
    Title
    Type
    NIDA CTN Dissemination Initiative
    Currently viewing
    Solicitation
    NIDA CTN Dissemination Initiative
    Sources Sought
    Similar Opportunities
    PREPARATION AND DISTRIBUTION OF RESEARCH DRUG PRODUCTS
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute on Drug Abuse (NIDA), is seeking proposals for the preparation and distribution of research drug products under a presolicitation notice. The contract will involve acquiring, importing, and exporting drugs and chemical compounds, as well as developing and analyzing various drug dosage forms, including marijuana and nicotine research cigarettes, to support drug abuse and addiction research. This contract is critical for maintaining a reliable supply of authentic controlled and uncontrolled drug compounds for the research community, with an anticipated award of one indefinite delivery, indefinite quantity (IDIQ) contract over a five-year period. Interested parties must possess a current DEA registration and comply with FDA’s current Good Manufacturing Practices, with proposals due approximately 45 days after the release of the RFP, expected on or about September 20, 2024. For further inquiries, contact Scott Duernberger at scott.duernberger@nih.gov or 301-594-0670.
    Surveys and Cognitive Tasks
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute on Drug Abuse (NIDA) and the National Institute of Mental Health (NIMH), is seeking a vendor for a non-competitive contract to provide account management, planning, and maintenance for online crowd-sourced surveys and cognitive tasks related to depression and anxiety. The primary objective is to facilitate participation in these surveys for individuals both with and without mental health conditions, thereby supporting research efforts in this critical area. This procurement falls under NAICS code 541910, with a contract period of one year, and is scheduled for award on or around September 23, 2024. Interested parties must submit their capability statements and proposals by September 23, 2024, at 9:00 a.m. Eastern Standard Time, to Robin Knightly at Robin.Knightly@nih.gov.
    Portfolio Impact Analysis for the Therapeutic Development Branch (TDB), NCATS
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking a contractor to conduct a Portfolio Impact Analysis for the Therapeutic Development Branch (TDB) within the National Center for Advancing Translational Sciences (NCATS). The objective of this procurement is to evaluate the TDB's research outcomes since its establishment in 2010, focusing on both economic and qualitative metrics to inform future research policies and strategic planning. This analysis is crucial for understanding the impact of TDB's partnerships, which have involved approximately 100 collaborations aimed at enhancing preclinical development, particularly for rare and neglected diseases. Interested firms, particularly those certified as Women-Owned Small Businesses, must submit their proposals by 2:00 PM ET on September 16, 2024, with a projected award date of September 23, 2024, and a performance period extending from September 24, 2024, to June 24, 2025. For further inquiries, contact Kimberly Espinosa at kimberly.espinosa@nih.gov.
    A Solicitation of the National Institutes of Health (NIH) and The Centers for Disease Control and Prevention (CDC) for Small Business Innovation Research (SBIR) Contract Proposals
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC) seek proposals from small businesses for innovative research projects under the Small Business Innovation Research (SBIR) program. The upcoming solicitation, PHS-2025-1, will open on August 2, 2024, with a closing date of October 18, 2024, and aims to foster healthcare technological innovation and commercialization. Research topics span cancer research, aging, and various health concerns. Offerors must demonstrate the technical and commercial viability of their proposals. This solicitation invites applications for Phase I, Fast Track, and Direct to Phase II projects, with evaluations based on scientific merit, commercial potential, and performance quality. Successful small businesses could receive funding for their research initiatives, contributing to NIH and CDC mission objectives.
    A--Request for Proposals - Phase I Clinical Trials
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health (NIH), is seeking proposals for Phase I clinical trials aimed at developing small molecule and biologics therapeutics, as outlined in RFP No. 75N95024R00086. The selected contractor will be responsible for comprehensive services including protocol development, trial management, and reporting to regulatory agencies, with a focus on safety, tolerability, and pharmacokinetics of the investigational therapeutics. This initiative is crucial for advancing therapeutic development in the field of neurology, ensuring compliance with FDA and ICH GCP standards throughout the trial process. Proposals are due by October 3, 2024, with a contract performance period from April 1, 2025, to March 31, 2035, and a maximum contract value of $233,227,446. Interested parties can contact Evan C. Feely at evan.feely@nih.gov or +1 301 827 5301 for further information.
    Evaluation of Semaglutide Safety and Tolerability in Adults with Cocaine Use Disorder with and without HIV and Assessment of Long-Acting Stimulants to Reduce Harm and HIV Transmission in Methamphetamine Use Disorder
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), intends to award a non-competitive federal contract for the evaluation of semaglutide safety and tolerability in adults with cocaine use disorder, as well as the assessment of long-acting stimulants to reduce harm and HIV transmission in methamphetamine use disorder. The contract will focus on conducting two clinical research studies in the Baltimore/Washington, DC region, aligning with NIH's priorities to address HIV and related health issues. The anticipated contract will span three years, starting on September 30, 2024, with the University of Maryland Medical Center as the intended recipient. Interested parties may express their capabilities and interest by contacting Susan Nsangou at susan.nsangou@nih.gov, as this opportunity does not involve a competitive proposal process.
    NIH Small Business Program Office | 2024 Outreach Activities
    Active
    Health And Human Services, Department Of
    Special Notice HEALTH AND HUMAN SERVICES, DEPARTMENT OF NIH Small Business Program Office | 2024 Outreach Activities The National Institutes of Health Small Business Program Office is organizing the May 2024 Vendor Outreach Engagement on Thursday, May 23, 2024, from 10:00 am to 12:00 pm in Bethesda, Maryland, United States. This event aims to expand and accelerate the National Institute of Environmental Health Sciences' contributions to scientific knowledge of human health and the environment. It also focuses on the health and well-being of people everywhere. The Office of Acquisitions, a full-service contracting organization, will provide comprehensive contracting services during the event. These services include Research and Development (R&D) contracting, Non-Research and Development (Non-R&D) contracting, Simplified acquisitions, Small business program assistance, and Purchase card oversight. To participate, interested companies must register by clicking the orange "Register" button on the event page. Each company is limited to four attendees, and there is a registration limit of 400 people. This event is free of charge and serves as a substitute for the NIH Small Business Program Office's May 2024 1-on-1 consultations. Additionally, the NIH Small Business Program Office presents the January 2024 Vendor Outreach Engagement - Newbie Open Forum. This forum, held on Wednesday, January 24th, 2024, from 11:00 am to 12:30 pm at Rockledge II, is specifically for prospective vendors who do not have NIH's past performance as a prime contractor. The forum provides an opportunity for vendors to interact with the NIH SBPO, learn about the NIH's contracting needs, and network with attendees. Space is limited for this event, with each company limited to one attendee. The registration limit is 40 people. Similar to the May 2024 event, this forum substitutes the NIH Small Business Program Office's January 2024 1-on-1 consultations and is free of charge. To join the NIH Small Business Office listserv, interested individuals can copy and paste the provided link into their web browser. The room number and additional details for the event will be provided the day before the event. Please ensure the success of this procurement notice to prevent my family from becoming homeless.
    A--PRECLINICAL MEDICATIONS SCREENING IN DEPENDENCE MO
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking proposals for a contract focused on preclinical medications screening in models of Alcohol Use Disorder (AUD). The objective of this procurement is to conduct blind testing of compounds supplied by developers using mouse models, with the contractor responsible for generating analyses and reports throughout the project. This initiative is crucial for advancing research in alcohol use disorder treatments and ensuring compliance with NIH policies on reproducibility and animal welfare. Proposals are due by September 18, 2024, with the contract period commencing on December 1, 2024, and extending through November 30, 2031. Interested parties can contact Lisa Schaupp at lisa.schaupp@nih.gov or 301-827-8135 for further information.
    National Cancer Institute (NCI) Small Business Innovation Research (SBIR) Innovative Concept Award Program – Fiscal Year 2025
    Active
    Health And Human Services, Department Of
    Presolicitation HEALTH AND HUMAN SERVICES, DEPARTMENT OF NATIONAL INSTITUTES OF HEALTH is seeking proposals from small businesses to develop innovative technologies for the treatment and prevention of Pediatric Cancers and/or Rare Cancers. The proposals should focus on the development of therapeutic or preventative technologies, devices, diagnostic technologies, or digital health tools. The aim is to demonstrate technical feasibility and proof-of-concept for highly innovative and potentially transformative technologies. The solicitation encourages proposals for rare cancers with a 5-year survival rate of less than 50%. The proposals should include experiments to obtain initial de-risking and proof-of-concept data. The awards will also include requirements to enhance entrepreneurship skills and develop a business model and commercialization plan. This is a total small business set-aside solicitation, and only eligible small businesses with no more than 500 employees will be considered. The solicitation is anticipated to be available on or around April 12, 2024, with a closing date in late September for receipt of proposals. Other SBIR and STTR contract and grant opportunities are also available. For more information, please refer to the NCI SBIR Program website.
    R--Clinical Support Services for NINDS, Stroke Branch
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health (NIH), is soliciting proposals for Clinical Support Services for the Stroke Branch of the National Institute of Neurological Disorders and Stroke (NINDS). The objective is to secure clinical support from an acute care hospital located within 15 miles of NIH, focusing on the evaluation and treatment of patients suffering from acute strokes and traumatic brain injuries, utilizing advanced MRI technology. This initiative is crucial for advancing research efforts in stroke therapy and ensuring compliance with ethical standards for human subject protections. Interested offerors must submit their proposals electronically via the NIH eCPS platform by September 9, 2024, and can direct inquiries to Marlene E. Milgram at MILGRAMM2@NIDA.NIH.GOV or by phone at +1 301 594 0864.